Dynamk Content — Dynamk Capital

Q4 2023 Quarterly Insights

Dynamk CapitalMarch 5, 2024

Q3 2023 Quarterly Insights

Dynamk CapitalOctober 24, 2023

Q2 2023 Quarterly Insights

Dynamk CapitalSeptember 5, 2023

Q4 2022 Quarterly Insights

Dynamk CapitalFebruary 11, 2023

Portfolio Companies like Envisagenics are Leveraging AI to Accelerate Drug Discovery

Portfolio Companies like Envisagenics are Leveraging AI to Accelerate Drug Discovery

portfolioDynamk CapitalJanuary 5, 2023

How Dynamk Capital Portfolio Companies are Accelerating Drug Discovery

How Dynamk Capital Portfolio Companies are Accelerating Drug Discovery

portfolioDynamk CapitalJanuary 4, 2023

Q3 2022 Quarterly Insights

Dynamk CapitalNovember 8, 2022

Venture Partner Reinhard Vogt Talks Biopharm Sector Growth with Pharma's Almanac

Venture Partner Reinhard Vogt Talks Biopharm Sector Growth with Pharma's Almanac

Dynamk CapitalSeptember 2, 2022

Q2-2022 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines

Q2-2022 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines

Dynamk CapitalAugust 20, 2022

Sebastien Latapie, Principal at Dynamk Capital, Sheds Light on the Rapidly Evolving AI/ML Landscape in RESI Panel

Sebastien Latapie, Principal at Dynamk Capital, Sheds Light on the Rapidly Evolving AI/ML Landscape in RESI Panel

Dynamk CapitalJuly 15, 2022

Q1-2022 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines

Q1-2022 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines

Dynamk CapitalMay 27, 2022

Life Science and Healthcare VC Checkup from the Venture Summit Conference

Life Science and Healthcare VC Checkup from the Venture Summit Conference

Dynamk CapitalApril 10, 2022

Venture Partner, Gustavo Mahler talks with the Pharma’s Almanac about the Next Big Thing in Pharma

Venture Partner, Gustavo Mahler talks with the Pharma’s Almanac about the Next Big Thing in Pharma

Dynamk CapitalApril 4, 2022

Q4-2021 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines

Q4-2021 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines

Dynamk CapitalMarch 1, 2022

Reinhard Vogt and Sebastien Latapie Discuss Filling Industry Gaps with Innovation in the Latest Pharma's Almanac

Reinhard Vogt and Sebastien Latapie Discuss Filling Industry Gaps with Innovation in the Latest Pharma's Almanac

Dynamk CapitalNovember 10, 2021

Q3-2021 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines

Q3-2021 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines

Q3-2021 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines

Dynamk CapitalOctober 25, 2021

Pharma's Almanac on the Road to 50 States

Pharma's Almanac on the Road to 50 States

Dynamk discusses the next BIG thing in Life Science Industrials while visted by Pharma’s Almanac on the Road to 50 States Tour

Dynamk CapitalOctober 12, 2021

Dynamk Capital and Pfizer Ventures Featured in Life Science Leader Article

Dynamk Capital and Pfizer Ventures Featured in Life Science Leader Article

Dynamk CapitalSeptember 28, 2021

Q2-2021 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines

Q2-2021 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines

Dynamk CapitalAugust 24, 2021

Q1-2021 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines

Q1-2021 Dynamk Life Science Industrials INSIGHTS: Trends, Transactions & Headlines